Skip to content

Depression: all studies

Page 805 of 1,034: studies 8,041 to 8,050 of 10,336, newest first. Back to the depression overview

Research

Positive Shifts in Emotion Evaluation Following Mindfulness-Based Cognitive Therapy (MBCT) in Remitted Depressed Participants

Mindfulness March 1, 2021 Kate Williams, Rebecca Elliott, Thorsten Barnhofer et al.

Abstract Objectives A combination of negatively biased information processing and a reduced ability to experience positive emotions can persist into remission from major depression (rMDD). Studies have shown that mindfulness-based cognitive therapy (MBCT) can increase self-reported positive emotions in rMDD participants; similar changes using neuropsychological tasks have not been shown. In...

Session on Psychedelics Sure to Be Enlightening

Psychiatric News March 1, 2021 Nick Zagorski

Back to table of contents Previous article Next article APA & MeetingsFull AccessSession on Psychedelics Sure to Be EnlighteningNick ZagorskiNick ZagorskiSearch for more papers by this authorPublished Online:2 Mar 2021https://doi.org/10.1176/appi.pn.2021.3.14AbstractLeaders in psychedelic research will discuss the therapeutic potential of psychedelic compounds in psychiatry and important...

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property

Frontiers in Pharmacology February 26, 2021 Guy A. Higgins, Nicole K. Carroll, Matthew A. Brown et al. 67 citations

Long term benefits following short-term administration of high psychedelic doses of serotonergic and dissociative hallucinogens, typified by psilocybin and ketamine respectively, support their potential as treatments for psychiatric conditions such as major depressive disorder. The high psychedelic doses induce perceptual experiences which are associated with therapeutic benefit. There have...

Prolonged epigenetic and synaptic plasticity alterations following single exposure to a psychedelic in mice

bioRxiv (Cold Spring Harbor Laboratory) February 25, 2021 Mario de la Fuente Revenga, Bohan Zhu, Christopher A. Guevara et al. 11 citations preprint

Clinical evidence suggests a potential therapeutic effect of classic psychedelics for the treatment of depression. The most outstanding and distinct characteristic is the rapid and sustained antidepressant action with one single exposure to the drug. However, the biological substrates and key mediators of psychedelics’ enduring action remain unknown. Here, we show that a single administration...

Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine

Translational Psychiatry February 24, 2021 Steven F. Grieco, X. Qiao, Kevin Johnston et al.

Subanesthetic ketamine evokes rapid antidepressant effects in human patients that persist long past ketamine’s chemical half-life of ~2 h. Ketamine’s sustained antidepressant action may be due to modulation of cortical plasticity. We find that ketamine ameliorates depression-like behavior in the forced swim test in adult mice, and this depends on parvalbumin-expressing (PV) neuron-directed...

Foundations of Human Consciousness: Imaging the Twilight Zone.

Journal of Neuroscience February 24, 2021 Annalotta Scheinin, Oskari Kantonen, Michael Alkire et al. 92 citations

What happens in the brain when conscious awareness of the surrounding world fades? We manipulated consciousness in two experiments in a group of healthy males and measured brain activity with positron emission tomography. Measurements were made during wakefulness, escalating and constant levels of two anesthetic agents (experiment 1, n = 39), and during sleep-deprived wakefulness and non-rapid...

DOI: 10.1523/jneurosci.0775-20.2020 (opens in new tab) Full text (opens in new tab) Anesthesia mechanisms Consciousness Dexmedetomidine Positron emission tomography +2

New Evidence in the Booming Field of Online Mindfulness: An Updated Meta-analysis of Randomized Controlled Trials

JMIR Mental Health February 23, 2021 Marion Sommers-Spijkerman, Judith Austin, Ernst T. Bohlmeijer et al.

Background There is a need to regularly update the evidence base on the effectiveness of online mindfulness-based interventions (MBIs), especially considering how fast this field is growing and developing. Objective This study presents an updated meta-analysis of randomized controlled trials assessing the effects of online MBIs on mental health and the potential moderators of these effects....

Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1

The Journal of Clinical Psychiatry February 23, 2021 Avinash Hosanagar, Joseph Michael Cusimano, Rajiv Radhakrishnan 9 citations

PsilocybinPsilocybin, derived from mushrooms belonging to the genus Psilocybe, and psilocin, its active metabolite, are indolamines.Recent studies have shown that psilocybin has effects on brain functional connectivity.14 Its effects include reducing negative affect and amygdala response to emotional faces at 1 week, with enduring changes in resting state functional connectivity (RSFC) at 1...

Widespread Cortical Thickness Reductions Following Non-medical Use of Ketamine: a Structural MRI Study of Individuals with Ketamine Dependence

medRxiv Preprint Server February 21, 2021 Jinsong Tang, Qiuxia Wu, Chang Qi et al. preprint

Background A version of ketamine, called Esketamine has been approved for treatment-resistant depression (TRD). Ketamine (“K powder”), a “dissociative” anesthetic agent, however, has been used non-medically alone or with other illicit substances. Our previous studies showed a link between non-medical ketamine use and brain structural and functional alterations. We found dorsal prefrontal gray...

DOI: 10.1101/2021.02.21.21252178 (opens in new tab) Full text (opens in new tab) Ketamine abuse Recreational ketamine use Illicit ketamine Ketamine dependence +11

Experiences of Mindfulness-Based Cognitive Therapy for Premanifest Huntington’s Disease

Journal of Huntington's Disease February 20, 2021 F. Eccles, D. Craufurd, Alistair M. S. Smith et al.

Background: Psychological difficulties such as anxiety, depression, and irritability are common in Huntington’s disease, even for premanifest individuals. However, very little evidence exists of psychological approaches to manage this distress. We have conducted a feasibility study with an embedded qualitative component to investigate the possibility of using mindfulness-based cognitive therapy...